Our work collectively highlights the vital role of SLC27A2 in regulating EMT signaling through CDK3 in ccRCC metastasis and suggests that functional inhibition of SLC27A2-CDK3-EMT axis may be an attractive therapeutic target for metastasis of ccRCC. This evidence concerns the gene CDK3 and nonpapillary renal cell carcinoma.